Ignite Creation Date:
2024-05-06 @ 9:37 AM
Last Modification Date:
2024-10-26 @ 12:16 PM
Study NCT ID:
NCT03020121
Status:
TERMINATED
Last Update Posted:
2018-01-31
First Post:
2017-01-11
Brief Title:
Validation of BD Onclarity HPV Assay With PreservCyt -ASCUS Samples
Sponsor:
Becton Dickinson and Company
Organization:
Becton Dickinson and Company
Study Overview
Official Title:
Validation of BD Onclarity HPV Assay With PreservCyt -ASCUS Samples
Status:
TERMINATED
Status Verified Date:
2018-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Lower than anticipated rate of subject enrollment
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the study is to compare the results of the Becton Dickinson BD Human Papilloma Virus HPV Assay on the Viper LT instrument from Liquid-based cytology media diluted in HPV diluent to adjudicated histology results from biopsy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None